Additionally, CDO1 shows promising diagnostic value in a few tumor types; for example, it could be an efficient strategy to determine minimal residual disease of the peritoneum in patients with gastric cancer (GC) [11, 12]. The gene discussed is CDO1; the disease is gastric cancer.